We currently do not have sufficient information about the CEO.
Key information
Marco Alfonsi
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
11.5yrs
CEO ownership
n/a
Management average tenure
8.4yrs
Board average tenure
8.1yrs
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
How has Marco Alfonsi's remuneration changed compared to Nascent Pharma Holdings's earnings?
Date
Total Compensation
Salary
Company Earnings
Sep 30 2024
n/a
n/a
-US$13m
Jun 30 2024
n/a
n/a
-US$14m
Mar 31 2024
n/a
n/a
-US$14m
Dec 31 2023
US$118k
US$10k
-US$10m
Sep 30 2023
n/a
n/a
-US$11m
Jun 30 2023
n/a
n/a
-US$14m
Mar 31 2023
n/a
n/a
-US$13m
Dec 31 2022
US$626k
US$26k
-US$15m
Sep 30 2022
n/a
n/a
-US$16m
Jun 30 2022
n/a
n/a
-US$12m
Mar 31 2022
n/a
n/a
-US$13m
Dec 31 2021
US$3m
US$107k
-US$12m
Sep 30 2021
n/a
n/a
-US$13m
Jun 30 2021
n/a
n/a
-US$11m
Mar 31 2021
n/a
n/a
-US$10m
Dec 31 2020
US$206k
US$113k
-US$9m
Sep 30 2020
n/a
n/a
-US$6m
Jun 30 2020
n/a
n/a
-US$6m
Mar 31 2020
n/a
n/a
-US$6m
Dec 31 2019
US$180k
US$180k
-US$6m
Compensation vs Market: Insufficient data to establish whether Marco's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Marco's compensation with company performance.
CEO
Marco Alfonsi (65 yo)
11.5yrs
Tenure
US$118,333
Compensation
Mr. Marco Alfonsi has been Chairman of the Board at Canbiola, Inc since June 15, 2017 and serves as its Chief Executive Officer since January 2015. He served as a Interim Secretary, Chief Financial Officer...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Marco Alfonsi
Chairman & CEO
11.5yrs
US$118.33k
no data
Stanley Teeple
CFO, Secretary & Director
7.8yrs
US$118.33k
no data
Greg Partin
Chief Information Officer
11.3yrs
no data
no data
Andrew Holtmeyer
Vice President of Business Development
8.4yrs
US$217.55k
no data
Pasquale Ferro
President of Pure Health Products LLC
7.6yrs
US$626.06k
no data
Steven Apolant
President of Green Grow Farms
no data
no data
no data
8.4yrs
Average Tenure
65yo
Average Age
Experienced Management: NASC's management team is seasoned and experienced (8.4 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Marco Alfonsi
Chairman & CEO
11.5yrs
US$118.33k
no data
Stanley Teeple
CFO, Secretary & Director
7.8yrs
US$118.33k
no data
Patrick Fratellone
Member of Medical Advisory Board
8.8yrs
no data
no data
Robert Kornfeld
Member of Medical Advisory Board
8.7yrs
no data
no data
Maciej Ferenc
Member of Medical Advisory Board
8.4yrs
no data
no data
John Salerno
Member of Medical Advisory Board
8.8yrs
no data
no data
Steven Medina
Member of Corporate Advisory Board
7.5yrs
no data
no data
John Bach
Member of Corporate Advisory Board
7yrs
no data
no data
Frederick Boyer
Independent Director
6.8yrs
no data
no data
James Murphy
Independent Director
6.8yrs
no data
no data
8.1yrs
Average Tenure
69.5yo
Average Age
Experienced Board: NASC's board of directors are considered experienced (8.1 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/13 05:06
End of Day Share Price
2026/07/09 00:00
Earnings
2024/09/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nascent Pharma Holdings, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.